The Wall Street Journal published recently an article called “IVF Testing Spurs a Debate Over Mosaic Embryos” with  the opinion of different speciaslits in IVF field. 

In words of Prof. Simón, our CSO, “Igenomix, tests embryos for about 200 U.S. clinics. Roughly 80% of those clinics classify embryos as either normal or abnormal and don’t want to know if one tests mosaic”. 

Access to the full article here